+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
Hepatitis B - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Hepatitis B - Global Clinical Trials Review, 2026

  • Clinical Trials
  • February 2026
  • 1910 Pages
  • Global
From
Acromegaly Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Acromegaly Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
USA Solid Tumor Therapeutics Market Outlook to 2028 - Product Thumbnail Image

USA Solid Tumor Therapeutics Market Outlook to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
Precision Medicine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Precision Medicine Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Loading Indicator